FDA Approved: SUNLENCA — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved Sunlenca (lenacapavir sodium) in an original application from Gilead Sciences for the treatment of HIV-1 infection. Lenacapavir is a novel antiretr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• SUNLENCA (LENACAPAVIR SODIUM)

Snippet

ORIG AP for SUNLENCA (LENACAPAVIR SODIUM)